RELMADA THERAPEUTICS, INC. - COM (RLMD)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
13.6M
Holdings value Q2 2024
$40.7M
Value change Q2 2024
-$3.03M
Grand Portfolio weight change Q2 2024
0%
Number of holders
78
Number of buys Q2 2024
21
Number of sells Q2 2024
-47
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 113 $366 $0 $3.24 1
2024 Q2 13.6M $40.7M -$3.03M $3.00 79
2024 Q1 14.3M $66.5M +$3.44M $4.65 89
2023 Q4 13.6M $56.3M -$3.31M $4.14 82
2023 Q3 15M $45M -$3.17M $3.00 87
2023 Q2 16.1M $39.6M -$4.05M $2.46 91
2023 Q1 17.8M $40.1M -$4.57M $2.26 87
2022 Q4 19.1M $66.8M -$457M $3.49 109
2022 Q3 25.8M $954M +$46.4M $37.02 138
2022 Q2 24.6M $468M +$33.5M $18.99 115
2022 Q1 23.1M $622M +$69.5M $26.99 112
2021 Q4 20.7M $467M +$239M $22.53 91
2021 Q3 10M $263M -$4.62M $26.21 80
2021 Q2 9.94M $318M +$11.6M $32.01 83
2021 Q1 9.54M $336M +$3.53M $35.21 81
2020 Q4 9.31M $299M -$48.4M $32.07 79
2020 Q3 10.4M $393M -$4.54M $37.62 74
2020 Q2 10.5M $469M +$57.8M $44.75 76
2020 Q1 9.36M $319M +$94.7M $34.11 42
2019 Q4 6.8M $265M +$265M $39.00 44